XML 29 R14.htm IDEA: XBRL DOCUMENT
v3.22.4

Earnings per Share | 12 Months Ended
--- | ---
Jan. 28, 2023
Earnings Per Share [Abstract] |
Earnings per Share | 6. Earnings per Share The following is a reconciliation between basic and diluted weighted average shares outstanding:
|  | For the Years Ended |
|  | January 28, |  |  | January 29, |  |  | January 30, |
(In thousands) |  | 2023 |  |  | 2022 |  |  | 2021 |
Numerator: |  |  |  |  |  |  |  |  |
Net income (loss) and numerator for basic EPS |  | $ | 125,136 |  |  | $ | 419,629 |  |  | $ | (209,274 | )
Add: Interest expense, net of tax, related to the 2025 Notes (1) |  |  | 5,474 |  |  |  | — |  |  |  | — |
Numerator for diluted EPS |  | $ | 130,610 |  |  | $ | 419,629 |  |  | $ | (209,274 | )
Denominator: |  |  |  |  |  |  |  |  |
Denominator for basic EPS - weighted average shares |  |  | 181,778 |  |  |  | 168,156 |  |  |  | 166,455 |
Add: Dilutive effect of the 2025 Notes (1) |  |  | 21,507 |  |  |  | 34,003 |  |  |  | — |
Add: Dilutive effect of stock options and non-vested restricted stock |  |  | 1,941 |  |  |  | 4,370 |  |  |  | — |
Denominator for diluted EPS - adjusted weighted average shares |  |  | 205,226 |  |  |  | 206,529 |  |  |  | 166,455 |
Anti-dilutive shares (2) |  |  | 2,182 |  |  |  | 202 |  |  |  | 14,259 |
(1) In Fiscal 2022, the Company adopted ASU 2020-06 under the modified retrospective method, which requires the Company to utilize the "if-converted" method of calculated diluted EPS. Accordingly, we did not restate financial information for prior periods. Refer to Note 2 to the Consolidated Financial Statements for additional information regarding the impact of the adoption of ASU 2020-06. (2) In Fiscal 2020, there were 1.9 million potentially dilutive equity awards and 12.4 million potentially dilutive shares from the 2025 Notes that were excluded from the diluted earnings per share calculation because the Company incurred a net loss for this period and their inclusion would be anti-dilutive. For all other periods presented, anti-dilutive shares relate to stock options and unvested restricted stock. Refer to Note 10 and Note 13 to the Consolidated Financial Statements for additional information regarding the 2025 Notes and share-based compensation, respectively.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration